✦ LIBER ✦
Safety, biodistribution, pharmacokinetics, and immunogenicity of99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
✍ Scribed by David R. Colnot; Jan C. Roos; Remco de Bree; Abraham J. Wilhelm; J. Alain Kummer; Gertraud Hanft; Karl-Heinz Heider; Gerd Stehle; Gordon B. Snow; Guus A. M. S. van Dongen
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 195 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.